Pathstone Holdings’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.8M Buy
96,026
+3,738
+4% +$1.28M 0.1% 143
2026
Q1
$32.5M Buy
92,288
+321
+0.3% +$114K 0.13% 123
2025
Q4
$30.1M Buy
91,967
+248
+0.3% +$78.7K 0.12% 133
2025
Q3
$25.9M Sell
91,719
-1,352
-1% -$392K 0.1% 137
2025
Q2
$26M Sell
93,071
-2,111
-2% -$598K 0.1% 126
2025
Q1
$29.6M Buy
95,182
+2,857
+3% +$844K 0.13% 121
2024
Q4
$24.1M Sell
92,325
-6,280
-6% -$1.86M 0.11% 130
2024
Q3
$31.8M Buy
98,605
+1,694
+2% +$554K 0.14% 109
2024
Q2
$30.3M Buy
96,911
+316
+0.3% +$92.8K 0.14% 106
2024
Q1
$27.5M Buy
96,595
+10,143
+12% +$2.97M 0.13% 112
2023
Q4
$25.6M Buy
+86,452
New +$23.6M 0.14% 109

Other funds holding AMGN

Pathstone Holdings's AMGN Position: Q2 2026 in Review

Pathstone Holdings increased its Amgen (AMGN) stake by 4.1% in Q2 2026, buying an estimated $1.28M and bringing the position to 96,026 shares worth $34.8M. The position accounts for 0.1% of the portfolio, ranked #143.

Pathstone Holdings first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pathstone Holdings held 96,026 shares of Amgen worth $34.8M as of Q2 2026.
  • Pathstone Holdings bought 3,738 Amgen shares in Q2 2026, an estimated $1.28M.
  • Amgen made up 0.1% of Pathstone Holdings's portfolio in Q2 2026, its #143 holding.
  • Pathstone Holdings first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.